**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 606-22-4 |2,6-Dinitroaniline | 97 | 210-108-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T+
Risk Phrases: 26/27/28 33
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Very toxic by inhalation, in contact with skin and if swallowed.
Danger of cumulative effects.The toxicological properties of this
material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological
properties of this substance have not been fully investigated.
Methemoglobinemia is characterized by dizziness, drowsiness,
headache, shortness of breath, cyanosis (bluish discoloration of skin
due to deficient oxygenation of the blood), rapid heart rate and
chocolate-brown colored blood. Overexposure may cause
methemoglobinemia.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. Methemoglobinemia
is characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
blood. Inhalation of aniline causes anoxia due to the formation of
methemoglobin.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death. There
is a danger of cumulative effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 606-22-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: orange-brown
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 132.00 - 134.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: practically insoluble
Specific Gravity/Density:
Molecular Formula: C6H5N3O4
Molecular Weight: 183.12
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 606-22-4: BX9200000
LD50/LC50:
Not available.
Carcinogenicity:
2,6-Dinitroaniline -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: DINITROANILINES
Hazard Class: 6.1
UN Number: 1596
Packing Group: II
IMO
Shipping Name: DINITROANILINES
Hazard Class: 6.1
UN Number: 1596
Packing Group: II
RID/ADR
Shipping Name: DINITROANILINES
Hazard Class: 6.1
UN Number: 1596
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T+
Risk Phrases:
R 26/27/28 Very toxic by inhalation, in contact with
skin and if swallowed.
R 33 Danger of cumulative effects.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 36/37 Wear suitable protective clothing and
gloves.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 606-22-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 606-22-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 606-22-4 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Succinamic Acid, 97%
| 638-32-4 |
|
Indole-6-Carboxylic Acid, 98+% (titr., dried basis)
| 1670-72-2 |
|
Methyl 2,2,2-Trichloroacetimidate, 98%
| 2533-69-9 |
|
(2R)-2-Boc-Amino-3-Phenylsulfonyl-1-(2-Tetrahydropyranyloxy)Propane,
| 0-01-1 |
|
2-Bromoethyl chloroformate, 97%
| 4801-27-8 |
|
4-Nitrobenzyl alcohol, 99%
| 619-73-8 |
|
4-Chlorotoluene, 98%
| 106-43-4 |
|
1,4-Dioxane-d8, 99 atom % D
| 123-91-1 |
|
1-Bromo-3-fluoropropane
| 352-91-0 |
|
(-)-Corey lactone benzoate
| 7732-18-5 |
|
4-Methoxy-3-buten-2-one, Tech., 90% (GC)
| 4652-27-1 |
|
1,2-Bis(diphenylphosphino)ethane
| 1663-45-2 |
|
Alpha, Alpha, Alpha-Tribromoquinaldine, 98+%
| 613-53-6 |
|
Methyl hydrazinocarboxylate, 97%
| 6294-89-9 |
|
2,6-Dinitroaniline, 97%
| 606-22-4 |
|
Alpha, Alpha-Dichlorotoluene, 95% (GC)
| 98-87-3 |
|
D-(+)-Turanose, 98%
| 547-25-1 |
|
Guanine Hydrochloride, 97% (UV-Vis)
| 635-39-2 |
|
Normal-Butylbenzene, 99+%
| 104-51-8 |
|
4-Cyanopyridine, 98%
| 100-48-1 |
|
1-Fluoro-3-nitrobenzene, 97%
| 402-67-5 |
|
(3-Cyanopropyl)trichlorosilane, 99+%
| 1071-27-8 |
|
Cholesteryl Myristate, Liquid Crystal, 97%
| 1989-52-2 |
|
4-Chloro-1,8-Naphthalic Anhydride, Tech., Contains ca 50% Moisture
| 4053-08-1 |
|
6-(Chloromethyl)uracil, 98%
| 18592-13-7 |
|
4,4'-Dipyridyl, 98%, Anhydrous
| 553-26-4 |
|
Aq 55s
| |
|
4-??n-(P-Methoxybenzylidene)Amino??Phenyl Acetate
| 10484-13-6 |
|
Tetraheptylammonium Iodide, 99% (Titr.)
| 3535-83-9 |
|
Abietic Acid, Tech., 85+% (titr.)
| 514-10-3 |
|
1,2,3,4-Tetrahydroquinoline, 98%
| 635-46-1 |
|
Fast Blue RR Salt
| 27766-45-6 |
|
6-Chloro-2,4-Dinitroaniline, 97%
| 3531-19-9 |
|
Tetrahexylammonium chloride
| 5922-92-9 |
|
3-Methyl-2-Nitrobenzyl Alcohol, 98%
| 80866-76-8 |
|
p-Fluorophenoxy-ethylbromide 95%
| 332-48-9 |
|
2-Chloro-2,2-diphenylacetyl chloride, 97%
| 2902-98-9 |
|
17-Methyltestosterone, 97.0-103.0% (on dry substance)
| 58-18-4 |
|
4-Fluorobenzoyl Chloride, 98%
| 403-43-0 |
|
3-Fluorophenol, 98%
| 372-20-3 |
|
1-(3-Dimethylaminopropyl)-3-Ethyl-Carbodiimide Hydrochloride, 98+%
| 25952-53-8 |
|
Poly(ethylene), Chlorosulfonated (contains 43% Cl, 1.1% S)
| 68037-39-8 |
|
2-Lepidylmalondialdehyde Sesquihydrate, 95%
| |
|
5-Bromosalicylaldehyde, 98%
| 1761-61-1 |
|
4-Morpholinobenzophenone, 99%
| 24758-49-4 |
|
Difurfurylsulfide, 96%
| 13678-67-6 |
|
3-(4-Fluorobenzoyl)-Propionic Acid, 97%
| 366-77-8 |
|
2-Formylphenoxyacetic acid, 98%
| 6280-80-4 |
|
3-Pentanol, 98%
| 584-02-1 |
|
Triphenylbismuth, 98% (GC)
| 603-33-8 |
|
|